MENU
+Compare
ACB
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$4.54
Change
+$0.06 (+1.34%)
Capitalization
257.14M

ACB Aurora Cannabis Forecast, Technical & Fundamental Analysis

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard... Show more

ACB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACB with price predictions
Nov 28, 2025

ACB's Stochastic Oscillator is staying in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for ACB crossed bearishly below the 50-day moving average on October 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACB entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACB's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on ACB as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACB just turned positive on November 25, 2025. Looking at past instances where ACB's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACB advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.675) is normal, around the industry mean (17.312). P/E Ratio (19.440) is within average values for comparable stocks, (72.847). ACB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). ACB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.962) is also within normal values, averaging (55.504).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
ACB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACB is expected to report earnings to fall 125.97% to 16 cents per share on February 05

Aurora Cannabis ACB Stock Earnings Reports
Q4'25
Est.
$0.17
Q3'25
Missed
by $0.68
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.39
The last earnings report on November 05 showed earnings per share of -64 cents, missing the estimate of 3 cents. With 591.49K shares outstanding, the current market capitalization sits at 257.14M.
A.I. Advisor
published General Information

General Information

a licensed producer of medical marijuana in Canada

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3498 63 Avenue
Phone
+1 855 279-4652
Employees
1130
Web
https://www.auroramj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPGF31.38N/A
N/A
Compass Group Plc
ERVFF0.04N/A
N/A
Boron One Holdings Inc.
INGEF3.38N/A
N/A
Ingenia Communities Group
KGFHY8.06N/A
N/A
Kingfisher plc
AVHHL0.72N/A
N/A
Avita Medical, Inc.

ACB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with SNDL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-0.99%
SNDL - ACB
65%
Loosely correlated
+1.79%
CGC - ACB
64%
Loosely correlated
-1.33%
OGI - ACB
63%
Loosely correlated
+0.64%
TLRY - ACB
62%
Loosely correlated
+885.43%
CRON - ACB
60%
Loosely correlated
-1.00%
More

Groups containing ACB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-0.99%
ACB
(2 stocks)
97%
Closely correlated
+3.15%
Pharmaceuticals: Generic
(213 stocks)
37%
Loosely correlated
+0.76%